Format

Send to

Choose Destination
Rheumatology (Oxford). 2017 May 1;56(5):679-688. doi: 10.1093/rheumatology/kew293.

Drug-induced hyperuricaemia and gout.

Author information

1
Department of Pharmacovigilance, Faculty of Medicine of Sousse and.
2
Medical Intensive Care Unit, Sahloul University Hospital, Sousse, Tunisia.

Abstract

Hyperuricaemia is a common clinical condition that can be defined as a serum uric acid level >6.8 mg/dl (404 µmol/l). Gout, a recognized complication of hyperuricaemia, is the most common inflammatory arthritis in adults. Drug-induced hyperuricaemia and gout present an emergent and increasingly prevalent problem in clinical practice. Diuretics are one of the most important causes of secondary hyperuricaemia. Drugs raise serum uric acid level by an increase of uric acid reabsorption and/or decrease in uric acid secretion. Several drugs may also increase uric acid production. In this review, drugs leading to hyperuricaemia are summarized with regard to their mechanism of action and clinical significance. Increased awareness of drugs that can induce hyperuricaemia and gout, and monitoring and prevention are key elements for reducing the morbidity related to drug-induced hyperuricaemia and gout.

KEYWORDS:

diuretics; drug-induced; gout; hyperuricaemia; management; organic anion transporters; prevention; uric acid

PMID:
27498351
DOI:
10.1093/rheumatology/kew293
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center